UPC vs DXST
Comparison between Universe Pharmaceuticals Inc (UPC, Company) and Decent Holding Inc (DXST, Company).
UPC is from the Healthcare sector, while DXST is from the Industrials sector.
UPC vs DXST - Performance Comparison
Key Characteristics
Financial metrics and valuation ratios
Market Cap
Winner
UPC
$1.66M
DXST
$1.65M
Max Drawdown
UPC
99.99%
Winner
DXST
98.46%
Sharpe Ratio
Winner
UPC
0.35
DXST
0.35
5Y Beta
Winner
UPC
0.51
DXST
0.73
Industry
UPC
Drug Manufacturers - Specialty & Generic
DXST
Waste Management
P/E Ratio
Winner
UPC
-0.00
DXST
0.78
PEG Ratio
UPC
N/A
DXST
0.06
Debt to Equity
UPC
3.75%
Winner
DXST
0.00%
Free Cash Flow Yield
UPC
N/A
DXST
-26.75%
P/S Ratio
UPC
N/A
DXST
0.32
P/B Ratio
UPC
N/A
DXST
1.85
UPC vs DXST - Historical Returns
Returns include dividend reinvestment.
1M
Winner
UPC
+8.65%
DXST
+4.52%
3M
Winner
UPC
+26.37%
DXST
-52.44%
6M
Winner
UPC
-33.72%
DXST
-94.26%
1Y
Winner
UPC
-24.87%
DXST
-92.82%
5Y(CAGR)
UPC
-80.84%
DXST
N/A
Max(CAGR)
Winner
UPC
-80.90%
DXST
-94.03%
UPC vs DXST - Annual Returns (2021 - 2026)
Returns include dividend reinvestment.
| Year | UPC | DXST |
|---|---|---|
| 2026 | -31.73% | -94.60% |
| 2025 | -85.20% | -65.76% |
| 2024 | -97.84% | N/A |
| 2023 | -78.91% | N/A |
| 2022 | -18.54% | N/A |
| 2021 | -65.58% | N/A |
UPC vs DXST Drawdown Comparison
The maximum drawdown for UPC was -99.99%, occurring on Mar 25, 2026. This drawdown has not yet recovered.
The maximum drawdown for DXST was -98.46%, occurring on May 29, 2026. This drawdown has not yet recovered.
The current UPC drawdown is -99.99%. The current DXST drawdown is -98.18%.
| Rank | UPC | DXST |
|---|---|---|
| #1 | -99.99% Apr 5, 2021 - Mar 25, 2026 | -98.46% Jan 22, 2025 - May 29, 2026 |
| #2 | -28.52% Mar 29, 2021 - Apr 5, 2021 | N/A |
| #3 | -14.74% Mar 23, 2021 - Mar 29, 2021 | N/A |
Correlation
Correlation between UPC and DXST is 0.41 which considered as a weak positive correlation - the stocks show a slight tendency to move together.
0.41
-101
Select Stocks to Compare
Popular: UPC vs SPYDXST vs SPY
More Comparisons
Compare with similar stocks